- Home
- FLNC vs ANGO Comparison
FLNC vs ANGO Comparison
Compare FLNC & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNC
- ANGO
- Stock Information
- Founded
- FLNC 2018
- ANGO 1988
- Country
- FLNC United States
- ANGO United States
- Employees
- FLNC N/A
- ANGO N/A
- Industry
- FLNC Industrial Machinery/Components
- ANGO Medical/Dental Instruments
- Sector
- FLNC Miscellaneous
- ANGO Health Care
- Exchange
- FLNC Nasdaq
- ANGO Nasdaq
- Market Cap
- FLNC 533.2M
- ANGO 439.5M
- IPO Year
- FLNC 2021
- ANGO 2004
- Fundamental
- Price
- FLNC $4.52
- ANGO $9.16
- Analyst Decision
- FLNC Buy
- ANGO Strong Buy
- Analyst Count
- FLNC 19
- ANGO 2
- Target Price
- FLNC $12.37
- ANGO $14.00
- AVG Volume (30 Days)
- FLNC 4.7M
- ANGO 330.5K
- Earning Date
- FLNC 05-07-2025
- ANGO 04-02-2025
- Dividend Yield
- FLNC N/A
- ANGO N/A
- EPS Growth
- FLNC N/A
- ANGO N/A
- EPS
- FLNC N/A
- ANGO N/A
- Revenue
- FLNC $2,329,871,000.00
- ANGO $283,320,000.00
- Revenue This Year
- FLNC $20.84
- ANGO N/A
- Revenue Next Year
- FLNC $21.68
- ANGO $6.35
- P/E Ratio
- FLNC N/A
- ANGO N/A
- Revenue Growth
- FLNC 6.08
- ANGO N/A
- 52 Week Low
- FLNC $3.46
- ANGO $5.47
- 52 Week High
- FLNC $26.12
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- FLNC 55.02
- ANGO 48.56
- Support Level
- FLNC $3.93
- ANGO $8.55
- Resistance Level
- FLNC $4.90
- ANGO $9.68
- Average True Range (ATR)
- FLNC 0.31
- ANGO 0.35
- MACD
- FLNC 0.17
- ANGO -0.02
- Stochastic Oscillator
- FLNC 83.96
- ANGO 58.68
About FLNC Fluence Energy Inc.
Fluence Energy Inc is enabling the global clean energy transition with market-leading energy storage products and services, and digital applications for renewables and storage. Geographically, it derives a majority of its revenue from the Americas.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.